Skip to main content Accessibility help
×
Hostname: page-component-84b7d79bbc-4hvwz Total loading time: 0 Render date: 2024-07-28T12:18:04.989Z Has data issue: false hasContentIssue false

2 - Overview of the clinical genetics of breast cancer

Published online by Cambridge University Press:  24 August 2009

Neva Haites
Affiliation:
University of Aberdeen, UK
Helen Gregory
Affiliation:
University of Aberdeen, UK
Patrick J. Morrison
Affiliation:
Belfast City Hospital, Belfast
Shirley V. Hodgson
Affiliation:
Guy's Hospital, London
Neva E. Haites
Affiliation:
University of Aberdeen
Get access

Summary

Introduction

Breast cancer is the most common cancer in women, accounting for 20% of all new cases of cancer. The lifetime risk to a woman in the UK is 1 in 12 females, with an incidence of less than 10 per 100 000 women aged under 30 years, rising to 300 per 100 000 in women aged over 85 years. Breast cancer can occur in sporadic and hereditary forms, and both forms are associated with modification to the genetic material. In the case of hereditary forms, a constitutive mutation in a specific gene predisposes individuals to cancer. In sporadic forms, mutations in somatic cells accumulate and result in transformation of a normal cell to one with malignant potential.

Statistical analysis of epidemiological data is compatible with a dominant gene (or genes) predisposing to breast cancer in certain families, with 5–10% of breast cancer being due to highly penetrant, dominant genes (Easton and Peto, 1990; Claus et al., 1991). Approximately 10% of isolated cases presenting under 35 years may be due to such a gene but only 1% of cases presenting over 80 years (Langston et al., 1996; Ford et al., 1998).

Table 2.1 lists genetic syndromes that may predispose to breast cancer, some of which will be discussed in this chapter and in some greater detail in subsequent chapters.

Family history as an indicator of predisposition to breast cancer

A history of breast cancer among relatives has been found, in epidemiological studies, to be an indication of breast cancer risk.

Type
Chapter
Information
Familial Breast and Ovarian Cancer
Genetics, Screening and Management
, pp. 6 - 21
Publisher: Cambridge University Press
Print publication year: 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×